HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay;HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
Free HTGM Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |